Skip to main content
. Author manuscript; available in PMC: 2015 Aug 1.
Published in final edited form as: Lancet. 2015 May 28;386(9991):350–359. doi: 10.1016/S0140-6736(14)62338-2

Table 1.

Baseline characteristics of patients

Continued methadone
(n=114)
Forced withdrawal
(n=109)
Total
(n=223)
Sex
  Male 87 (76%) 86 (79%) 173 (78%)
  Female 27 (24%) 23 (21%) 50 (22%)

Ethnic origin
  White 93 (81%) 88 (81%) 181 (81%)
  Black 3 (3%) 6 (6%) 9 (4%)
  Other 18 (16%) 15 (14%) 33 (15%)
  Non-Hispanic 97 (85%) 95 (87%) 192 (86%)
  Hispanic 17 (15%) 14 (13%) 31 (14%)

Age at baseline (years) 33 (8·0)
30 (27–54)
36 (8·7)
33 (29–40)
34 (8·4)
32 (27–40)

Number of years in education
  Did not finish high school 48 (42%) 41 (37%) 89 (40%)
  Finished high school 41 (36%) 40 (37%) 81 (36%)
  College or higher education 25 (22%) 28 (26%) 53 (24%)

Self-reported positive hepatitis C status 36 (32%) 48 (44%) 84 (38%)

Duration of incarceration (days) 56 (47) 56 (42) 56 (45)
42 (17–76) 45 (16–80) 44 (17–78)

Methadone use (weeks) 156 (164); n=112
104 (28–224)
239 (280); n=109
156 (52–312)
197 (232); n=221
112 (32–260)

Methadone dose
  Most recent methadone dose (mg) 92 (52); n=111
80 (57–115)
95 (67); n=106
80 (51–110)
93 (60); n=217
80 (55–110)
Maintenance dose (mg) 98 (47); n=94
87·5 (60–115)
93 (49); n=89
80 (60–110)
96 (48); n=183
80 (60–115)

Detox status before incarceration* 6 (5%) 12 (11%) 18 (8%)

Drug use
  Heroin use (years) 8 (7); n=97
6 (2–11)
9 (7); n=97
8 (3–12)
8 (7); n=194
7 (3–12)
  Use of other opioids (years) 8 (7); n=82
5 (2–10)
8 (5); n=67
6 (3–10)
8 (6); n=149
6 (3–10)
  Previous use of injectable drugs 88 (77%) 91 (86%) 179 (80%)

Addiction Severity Index drug subscale score at baseline 0·23 (0·13)
0·22 (0·10–0·33)
0·27 (0·13)
0·28 (0·15–0·38)
0·25 (0·14)
0·25 (0·13–0·36)

Data are n (%), mean (SD), or median (IQR).

*

Participants with a clinical status of detox before their incarceration were undergoing methadone withdrawal.